Australian Clinical Labs Denies Claims Made in Class Action Filed in Victorian Supreme Court
MT Newswires Live
Apr 21
Australian Clinical Labs (ASX:ACL) denied the claims made in the representative proceeding filed in the Victorian Supreme Court by a Michelle Raab-Ivanov and plans to "vigorously" defend it, according to a Tuesday filing with the Australian bourse.
The proceeding was expressed to be on behalf of persons who were customers of the company and/or its Medlab Pathology subsidiary before July 15, 2022, and whose personal information was affected by a cyberattack on Medlab Pathology in February 2022, the filing said.
The statement of claim purports to seek damages for affected individuals based on alleged breaches of the Australian Consumer Law, per the filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.